Another aspect to consider is the experience of Nansonic's CEO, Michael Kavanagh who came to NAN from Cochlear.
He spent most of his years at Nanosonics heading up the global marketing arm of Cochlear. While continued R&D is important for the longer term prospects of NAN; in the short-medium term it's all about sales. Hopefully his sales experience from COH will hold him in good stead at NAN.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$3.87 |
Change
0.050(1.31%) |
Mkt cap ! $1.175B | |||
| Open | High | Low | Value | Volume |
| $3.80 | $3.88 | $3.70 | $2.871M | 747.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2760 | $3.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.90 | 2950 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| NAN (ASX) Chart |